Table 4.
Treatment | Number of patients | Response duration (days) | Effective rate (%) | Incidence of adverse events (%) |
---|---|---|---|---|
CYC | 72 | 5.2±1.03 | 72.2 | 17.3 |
MTX+DXM | 84 | 2.3±0.95 | 90.5 | 6.0 |
χ2 or t | - | 6.539 | 4.386 | 5.112 |
p | - | <0.001 | 0.036 | 0.024 |
Treatment | Number of patients | Response duration (days) | Effective rate (%) | Incidence of adverse events (%) |
---|---|---|---|---|
CYC | 72 | 5.2±1.03 | 72.2 | 17.3 |
MTX+DXM | 84 | 2.3±0.95 | 90.5 | 6.0 |
χ2 or t | - | 6.539 | 4.386 | 5.112 |
p | - | <0.001 | 0.036 | 0.024 |